Open access · CC-BY
via OpenAlex
Insulin resistance and sarcopenia: mechanistic links between common co-morbidities
Mark E. Cleasby, Pauline Jamieson, Philip J. Atherton
Journal of Endocrinology · 2016 · ▲ 752 citations
Abstract
Insulin resistance (IR) in skeletal muscle is a key defect mediating the link between obesity and type 2 diabetes, a disease that typically affects people in later life. Sarcopenia (age-related loss of muscle mass and quality) is a risk factor for a number of frailty-related conditions that occur in the elderly. In addition, a syndrome of 'sarcopenic obesity' (SO) is now increasingly recognised, which is common in older people and is applied to individuals that simultaneously show obesity, IR and sarcopenia. Such individuals are at an increased risk of adverse health events compared with those who are obese or sarcopenic alone. However, there are no licenced treatments for sarcopenia or SO, the syndrome is poorly defined clinically and the mechanisms that might explain a common aetiology are not yet well characterised. In this review, we detail the nature and extent of the clinical syndrome, highlight some of the key physiological processes that are dysregulated and discuss some candidate molecular pathways that could be implicated in both metabolic and anabolic defects in skeletal muscle, with an eye towards future therapeutic options. In particular, the potential roles of Akt/mammalian target of mTOR(definition)-inhibiting drug studied for extending healthspan and lifespan." style="text-decoration:underline dotted; text-underline-offset:2px; cursor:help;">rapamycin(definition) signalling, AMP-activated protein kinase, myostatin, urocortins and vitamin D are discussed.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1530/joe-15-0533
- Canonical
- link ↗
- Fetched
- 2026-06-07 MST
Cite this
APA
Cleasby, M.E., Jamieson, P., & Atherton, P.J. (2016). Insulin resistance and sarcopenia: mechanistic links between common co-morbidities. <em>Journal of Endocrinology</em>. https://doi.org/10.1530/joe-15-0533
Vancouver
Cleasby ME, Jamieson P, Atherton PJ. Insulin resistance and sarcopenia: mechanistic links between common co-morbidities. Journal of Endocrinology. 2016. doi:10.1530/joe-15-0533.
BibTeX
@article{mark2016Insuli,
title = {Insulin resistance and sarcopenia: mechanistic links between common co-morbidities},
author = {Mark E. Cleasby and Pauline Jamieson and Philip J. Atherton},
journal = {Journal of Endocrinology},
year = {2016},
doi = {10.1530/joe-15-0533},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Proceedings of The Nutrition Society 2015
Open access · OA
Muscle loss and obesity: the health implications of sarcopenia and sarcopenic obesity
University of Lausanne 2010
Open access · US-GOV
In French AGIR Means to Get Into Action. This is the Generic Title of Our Study.
International Journal of Molecular Sciences 2020
Open access · CC-BY
Pathophysiology of Type 2 Diabetes Mellitus
Ayşe Ukbe Baykut 2024
Open access · US-GOV
The Effect of Acupuncture on Sarcopenia and Obesity in Patients With Sarcopenic Obesity.
Cell and Tissue Research 2018
Citation only
Skeletal muscle fibrosis: an overview
Singapore General Hospital 2025
Open access · US-GOV